Same Drug Class

Nivolumab vs Tamoxifen

Nivolumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between Nivolumab and Tamoxifen.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Tamoxifen: Selective estrogen receptor modulator (SERM).

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Tamoxifen β€” 5-7 days.

Chemical Properties

Molecular Formula: Tamoxifen β€” C26H29NO.

Molecular Weight: Tamoxifen β€” 371.5150 g/mol.

Type: Nivolumab β€” Antibody; Tamoxifen β€” Small molecule.